Filing Details

Accession Number:
0000914190-19-000424
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-26 16:25:26
Reporting Period:
2019-11-25
Accepted Time:
2019-11-26 16:25:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1196298 Nephros Inc NEPH Surgical & Medical Instruments & Apparatus (3841) 133971809
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1749836 J. Oliver Spandow C/o Nephros, Inc.
380 Lackawanna Place
South Orange NJ 07079
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-25 1,000 $8.17 10,786 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $5.58 2028-08-10 9,466 9,466 Direct
Common Stock Stock Option (Right to Buy) $5.85 2028-12-19 5,161 5,161 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-08-10 9,466 9,466 Direct
2028-12-19 5,161 5,161 Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.079 to $8.50. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The option vests as to 3,156 shares on 8/10/19 and as to 3,155 shares on each of 8/10/20 and 8/10/21.
  3. The option vests as to 1,721 shares on 12/19/18 and as to 1,720 shares on each of 12/19/19 and 12/19/20.